banditolino : Deinove: Opening access to new active ingredients
To increase their competitiveness, microorganisms dedicate a large portion of their genomes to the production of secondary metabolites (antimicrobials, alkaloids, flavonoids, terpenoids, polyketides, non-ribosomal peptides...). A single microbe is able to produce 30-50 natural compounds  leading to an almost unlimited source of secondary metabolites within the microbial world. To date, less than 0.1% of biodiversity has been exploited but the benefits of this exploration are already considerable. In 150 years, thousands of natural products have been developed for health (antimicrobials, anti-cancer drugs, cardiotonic agents, analgesics...), nutrition and cosmetics (antioxidants, colorants, emulsifiers, preservatives...).
By recently revealing the existence of an immense microbial dark matter, scientists have opened the way to the exploitation of an unsuspected metabolic diversity. DEINOVE has established its position as a pioneer in this exploitation by developing a unique collection of rare strains and acquiring cutting-edge expertise in genetic, metabolic and fermentation engineering, thus firmly stepping onto the territory of previously unknown, uncultivatable or poorly studied microorganisms with complex genetic profiles.